Gene/Event |
Cancer Type |
Patient |
Variant |
Mutation Level |
TET2 |
Bladder Cancer | p076_MSK-0754 |
p.E294K |
Trunk mutation |
TET2 |
Bladder Cancer | p084_p3 |
- |
Trunk mutation |
TET2 |
Breast Cancer | p111_p8-82 |
p.E1357Q |
Branch mutation |
TET2 |
Breast Cancer | p143_p5 |
Chr4:106157384:A>G |
Private mutation |
TET2 |
Osteosarcoma | p102_OS03 |
Chr4:106197290:T>A |
Branch mutation |
TET2 |
Colorectal Cancer | p001_PCRC12 |
Chr4:106197633:A>T |
Private mutation |
TET2 |
Colorectal Cancer | p014_CRC2 |
p.H1382H |
Trunk mutation |
TET2 |
Colorectal Cancer | p034_MSU4 |
Chr4:106180785:C>T |
Private mutation |
TET2 |
Colorectal Cancer | p069_p14 |
p.Q373K |
Trunk mutation |
TET2 |
Colorectal Cancer | p069_p17 |
p.Q373K |
Private mutation |
TET2 |
Colorectal Cancer | p075_p1 |
p.E1151X |
Branch mutation |
TET2 |
Endometrial Cancer | p042_EC007 |
p.S838fs |
Branch mutation |
TET2 |
Esophageal Squamous Cell Carcinoma | p124_ESCC012 |
p.R1302T |
Branch mutation |
TET2 |
Esophageal Squamous Cell Carcinoma | p124_ESCC022 |
p.A289S |
Trunk mutation |
TET2 |
Esophageal Squamous Cell Carcinoma | p128_P11 |
Chr4:106157022:G>T |
Private mutation |
TET2 |
Esophageal Squamous Cell Carcinoma | p128_SP14 |
Chr4:106158370:A>G |
Private mutation |
TET2 |
Esophageal Squamous Cell Carcinoma | p128_SP25 |
Chr4:106162570:G>T |
Private mutation |
TET2 |
Esophageal Squamous Cell Carcinoma | p128_SP27 |
Chr4:106155895:C>A |
Private mutation |
TET2 |
Esophageal Squamous Cell Carcinoma | p139_EC1020 |
p.S1611Y |
Private mutation |
TET2 |
Gastric Carcinoma | p106_GC09 |
p.Y620H |
Private mutation |
TET2 |
Glioblastoma | p113_case01 |
p.R1516* |
Private mutation |
TET2 |
Glioma | p168_P01 |
p.L18L |
Branch mutation |
TET2 |
Glioma | p168_P01 |
p.D648D |
Branch mutation |
TET2 |
Glioma | p168_P01 |
p.T859I |
Private mutation |
TET2 |
Hepatocellular Carcinoma | p061_P08 |
Chr4:106155931:C>G |
Branch mutation |
TET2 |
Lung Cancer | p028_RJLC4-T1 |
p.A912V |
Trunk mutation |
TET2 |
Lung Adenocarcinoma | p109_p1-9450 |
p.A1045D |
Trunk mutation |
TET2 |
Lung Adenocarcinoma | p109_p3-6610 |
p.S1050X |
Private mutation |
TET2 |
Non-Small Cell Lung Cancer | p148_p02 |
p.R814S |
Trunk mutation |
TET2 |
Non-Small Cell Lung Cancer | p148_p02 |
p.K1338N |
Private mutation |
TET2 |
Melanoma | p043_F |
p.P1889S |
Trunk mutation |
TET2 |
Melanoma | p043_H |
p.V1199M |
Private mutation |
TET2 |
Myeloma | p097_04 |
- |
Branch mutation |
TET2 |
Myeloma | p097_19 |
- |
Branch mutation |
TET2 |
Myeloma | p097_24 |
- |
Branch mutation |
TET2 |
Myeloma | p097_34 |
- |
Branch mutation |
TET2 |
Ovarian Cancer | p153_RJOC08 |
p.I1762V |
Private mutation |
TET2 |
Prostate Cancer | p118_CPCG0184 |
p.I1762V |
Branch mutation |
TET2 |
Prostate Cancer | p164_P1 |
p.V218M |
Branch mutation |
TET2 |
Prostate Cancer | p164_P2 |
p.V218M |
Branch mutation |
TET2 |
Clear Cell Renal Cell Carcinoma | p025_CCCFP2 |
- |
Trunk mutation |
TET2 |
Clear Cell Renal Cell Carcinoma | p025_CCCFP2 |
- |
Branch mutation |
TET2 |
Clear Cell Renal Cell Carcinoma | p025_CCCFP19 |
- |
Branch mutation |
TET2 |
Clear Cell Renal Cell Carcinoma | p025_CCCFP21 |
- |
Trunk mutation |
TET2 |
Clear Cell Renal Cell Carcinoma | p025_CCCFP29 |
- |
Trunk mutation |
TET2 |
Clear Cell Renal Cell Carcinoma | p121_p218 |
p.D1142fs |
Trunk mutation |
TET2 |
Renal Cell Carcinoma | p073_RCC3 |
Chr4:106190972:C>T |
Private mutation |
TET2 |
Renal Cell Carcinoma | p073_RCC4 |
Chr4:106197262:T>C |
Trunk mutation |
TET2 |
Urothelial Carcinoma | p142_p33 |
- |
Private mutation |